PRIMARY SJÖGREN'S SYNDROME
Clinical trials for PRIMARY SJÖGREN'S SYNDROME explained in plain language.
Never miss a new study
Get alerted when new PRIMARY SJÖGREN'S SYNDROME trials appear
Sign up with your email to follow new studies for PRIMARY SJÖGREN'S SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a single injection tame lupus and Sjögren's?
Disease control Not yet recruitingThis early-stage trial is evaluating an investigational drug called QLS2404, given as an injection, to see if it is safe and tolerable. The study first tests single doses in healthy volunteers, then moves to multiple doses in people with systemic lupus erythematosus or primary Sj…
Matched conditions: PRIMARY SJÖGREN'S SYNDROME
Phase: PHASE1 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can a pill tame Sjögren's? a new drug puts the immune system to the test
Disease control Not yet recruitingThis phase 2 trial is testing whether an oral drug called ICP-488 can reduce disease activity in people with primary Sjögren's syndrome, an autoimmune condition that causes dry eyes, dry mouth, and fatigue. About 240 adults aged 18 to 70 with moderate-to-active disease will recei…
Matched conditions: PRIMARY SJÖGREN'S SYNDROME
Phase: PHASE2 • Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Immune retraining: could CAR-Treg cells tame autoimmune disease?
Disease control Not yet recruitingThis early-phase study tests a new treatment called BEN301, which uses specially engineered immune cells (CAR-Tregs) to calm overactive immune responses in people with autoimmune diseases like scleroderma, rheumatoid arthritis, lupus, and inflammatory muscle disease. The trial wi…
Matched conditions: PRIMARY SJÖGREN'S SYNDROME
Phase: EARLY_PHASE1 • Sponsor: Beijing Boren Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC